Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Related Articles by Review for PubMed (Select 23492920)

1.

Deriving dopaminergic neurons for clinical use. A practical approach.

Gonzalez R, Garitaonandia I, Abramihina T, Wambua GK, Ostrowska A, Brock M, Noskov A, Boscolo FS, Craw JS, Laurent LC, Snyder EY, Semechkin RA.

Sci Rep. 2013;3:1463. doi: 10.1038/srep01463.

2.

Molecular manipulation targeting regulation of dopaminergic differentiation and proliferation of neural stem cells or pluripotent stem cells.

Ding YX, Wei LC, Wang YZ, Cao R, Wang X, Chen LW.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):517-28. Review.

PMID:
21495963
3.
4.

Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Dev Biol. 2013 Jul 15;379(2):123-38. doi: 10.1016/j.ydbio.2013.04.014. Epub 2013 Apr 18. Review.

5.

Modulation of dopaminergic neuronal differentiation from sympathoadrenal progenitors.

Vukicevic V, Rubin de Celis MF, Diaz-Valencia G, Bornstein SR, Ehrhart-Bornstein M.

J Mol Neurosci. 2012 Oct;48(2):420-6. Epub 2012 Mar 25. Review.

PMID:
22447400
6.

Derivation of dopaminergic neurons from pluripotent stem cells.

Studer L.

Prog Brain Res. 2012;200:243-63. doi: 10.1016/B978-0-444-59575-1.00011-9. Review.

PMID:
23195422
7.

Modulation of the generation of dopaminergic neurons from human neural stem cells by Bcl-X(L): mechanisms of action.

Martínez-Serrano A, Castillo CG, Courtois ET, García-García E, Liste I.

Vitam Horm. 2011;87:175-205. doi: 10.1016/B978-0-12-386015-6.00029-9. Review.

PMID:
22127243
8.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
9.

Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.

Cooper O, Parmar M, Isacson O.

Prog Brain Res. 2012;200:265-76. doi: 10.1016/B978-0-444-59575-1.00012-0. Review.

PMID:
23195423
10.

Differentiating human stem cells into neurons and glial cells for neural repair.

Selvaraj V, Jiang P, Chechneva O, Lo UG, Deng W.

Front Biosci (Landmark Ed). 2012 Jan 1;17:65-89. Review.

PMID:
22201733
11.

Clinical application of stem cell therapy in Parkinson's disease.

Politis M, Lindvall O.

BMC Med. 2012 Jan 4;10:1. doi: 10.1186/1741-7015-10-1. Review.

12.

Pluripotent stem cells for Parkinson's disease: progress and challenges.

Zeng X, Couture LA.

Stem Cell Res Ther. 2013 Apr 15;4(2):25. doi: 10.1186/scrt173. Review.

13.

Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.

Freed CR, Zhou W, Breeze RE.

Neurotherapeutics. 2011 Oct;8(4):549-61. doi: 10.1007/s13311-011-0082-9. Review.

14.

Modeling Parkinson's disease using induced pluripotent stem cells.

Byers B, Lee HL, Reijo Pera R.

Curr Neurol Neurosci Rep. 2012 Jun;12(3):237-42. doi: 10.1007/s11910-012-0270-y. Review.

15.

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

Nishimura K, Takahashi J.

Biol Pharm Bull. 2013;36(2):171-5. Review.

16.

Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons.

Alwin Prem Anand A, Gowri Sankar S, Kokila Vani V.

J Cell Mol Med. 2012 Nov;16(11):2592-610. doi: 10.1111/j.1582-4934.2012.01607.x. Review.

17.

Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Levy YS, Stroomza M, Melamed E, Offen D.

J Mol Neurosci. 2004;24(3):353-86. Review.

PMID:
15655260
18.

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.

Lescaudron L, Naveilhan P, Neveu I.

Curr Med Chem. 2012;19(35):6018-35. Review.

PMID:
22963567
19.

Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives.

Anisimov SV.

Rev Neurosci. 2009;20(5-6):347-81. Review.

PMID:
20397620
20.

Cell replacement therapy for Parkinson's disease: how close are we to the clinic?

Ganz J, Lev N, Melamed E, Offen D.

Expert Rev Neurother. 2011 Sep;11(9):1325-39. doi: 10.1586/ern.11.74. Review.

PMID:
21864078
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk